Wild inflation will hurt all financial assets, market researcher Jim Bianco warns

Wild inflation will hurt all financial assets, market researcher Jim Bianco warns


There may be no escape from the bond market turmoil — even for stock investors.

Market researcher Jim Bianco warns critical Federal Reserve policies to control wild inflation will inflict widespread losses on Wall Street.

“Eventually, this is going to come back and hurt all financial assets,” the Bianco Research president told CNBC “Fast Money” on Thursday.

Bianco turned bearish on stocks late last year, primarily due to inflation risks. He blames the Fed for waiting too long to end its pandemic easy money policies and lift interest rates.

“The call last year that inflation would be well-contained and transitory is arguably one of the worst forecasts in Federal Reserve history,” said Bianco. “They are now stuck with this ultra-aggressive policy because they didn’t start raising rates at a very leisurely pace a year ago.”

He worries about the big catch-up’s costs.

“They don’t intend on creating a hard landing. But what they do intend on doing is reining in prices,” Bianco said. “They want lower inflation, and they’re going to raise rates til they get lower inflation. How are they going to do that? They’re going to slow demand down.”

According to Bianco, the Fed’s only solution is to boot interest rates quickly and get wealthy people to stop spending. The bond market is already discounting the central bank’s likely bold moves.

“The bond market gets it. The carnage is epic,” he wrote in a recent Twitter thread. “This is not only the worst bond market in our career (total return) but might be the worst of our lifetime.”

Bianco, who sees a 75% chance of inflation within the next two years, expects a 50 basis point hike at its next policy meeting on May 3 through May 4.

“It will be 50 [basis points] all the way through until the Fed basically raises rates too much and breaks something. And, then they’ll be done. But, they’re not going to go back to 25,” he said. “If the stock market wants to go up, maybe they should be talking about 75 instead of 50.”

Bianco contends the Fed is aware the stakes are high.

“They don’t want to create the mistake in the other direction by being too timid right now. That’s out the window now,” Bianco said. “They don’t want to create a broken market. They don’t want to create a recession. But when you go down that path and you’re that adamant about trying to rein in inflation, it makes it very likely that you will create a mistake.”

Disclaimer



Source

Citi UK CEO: ‘Phenomenal’ market resilience is keeping recession risk at bay — for now
World

Citi UK CEO: ‘Phenomenal’ market resilience is keeping recession risk at bay — for now

Tiina Lee, the CEO of Citi U.K., expects global growth to remain resilient this year, telling CNBC that a “recessionary environment” is “not our base case.” Markets have continued to perform in an orderly way, despite the economic and geopolitical upheaval caused by the Iran conflict, which entered its 60th day on Tuesday, Lee said. […]

Read More
‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.
World

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.

Manus was hailed by Chinese state media as the “next DeepSeek” soon after its launch in March 2025, months before the startup relocated to Singapore. Cheng Xin | Getty Images News | Getty Images BEIJING — China’s decision to block U.S. tech giant Meta‘s $2 billion acquisition of artificial intelligence startup Manus is being seen […]

Read More
Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’
World

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and the reality will soon catch up with both drugmakers and patients. “The longer-term implications are significant,” CEO Vas Narasimhan told CNBC’s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change […]

Read More